º»¹® ¹Ù·Î°¡±â

·Î±×ÀÎ ¹Ù·Î°¡±â


ÇÁ·Î¸Þ°¡ÄÚ¸®¾Æ(À¯) ±â¾÷Á¤º¸

ÇÁ·Î¸Þ°¡ÄÚ¸®¾Æ(À¯)

°ü½É±â¾÷ Ãß°¡Çϰí ä¿ë¼Ò½Ä ¹Þ±â

  • »ý¸í°úÇÐ ½Ã¾à ¹× ±â±âÀÇ ÆÇ¸Å, ¸¶ÄÉÆÃ ¹× À¯Åë
    Á¦Ç°ÀÇ º¸°ü ¹× Áö¿ª ½Ç¼ö¿äÀÚ¿Í ÆÇ¸Å¾÷ÀÚ¿¡°Ô ¹è¼ÛÇÏ´Â ¹°·ù¿î¿µ
    ¿Â¶óÀÎ ¹× ÀüÅëÀû °Å·¡¸¦ Æ÷ÇÔÇÏ´Â ÁÖ¹®Ã³¸® ¹× ´ë±Ýû±¸
    ¿Â¶óÀÎ ¸¶ÄÉÆÃÀ» Æ÷ÇÔÇÏ´Â ¸¶ÄÉÆÃ Àü·« ¹× Àü¼úÀÇ °³¹ß ¹× ½ÇÇà
    ÆÇ¸Å ¹× Áö¿øÈ°µ¿À» À§ÇÑ ¿µ¾÷ »ç¿ø ¹èÄ¡
    ±â±â»ç¿ë¿¡ ´ëÇÑ ¼­ºñ½º ¹× Áö¿ø
    ÆÇ¸Å¾÷ÀÚ ¹× ½Ç¼ö¿äÀÚ¿¡°Ô ±³À° Á¦°ø
    À§ °¢Ç×°ú °ü·ÃµÈ »ç¾÷ ÀÏü
  • ´ëÇ¥ÀÚ³ªÁ¤¾Æ,Àª¸®¾Ï¿¡À̸°Æ°,³ªÁ¤¾Æ,Àª¸®¾Ï¿¡À̸°Æ°
  • ¼³¸³ÀÏ2009³â 8¿ù 6ÀÏ
  • ¸ÅÃâ¾× 232¾ï 1,690¸¸¿ø (2023)
  • »ç¿ø¼ö 21 ¸í ÀçÁ÷Áß
  • Æò±Õ¿¬ºÀ7,655¸¸¿ø
  • ÀÚº»±Ý 5,250¸¸¿ø

ȸ»ç¼Ò°³

ȸ»ç¼Ò°³

Promega CorporationÀº ¹Ì±¹ WisconsinÁÖ Madison¿¡ À§Ä¡Çϰí ÀÖÀ¸¸ç Àü¼¼°è 14°³±¹¿¡ Áö»ç ¹× Àü ¼¼°èÀûÀ¸·Î50¿© °³ÀÇ Global channelÀ» µÐ ¼¼°èÀûÀÎ »ý¸í°øÇÐ(LifeScience)±â¾÷ ÀÔ´Ï´Ù. 1978³â ¼³¸³ ÀÌÈÄ, ÇöÀç ¾à 1000¸íÀÇ ÀÓÁ÷¿øµéÀÌ 2000¿© °¡ÁöÀÇ Á¦Ç° °³¹ß¿¡ Èû¾²°í ÀÖÀ¸¸ç ÃÖ Ã·´Ü »ý¸í°øÇÐ ¹× À¯ÀüÀÚ ºÐ¼® µîÀÇ ºÐ¾ß¿¡¼­ ¼¼°è ±â¼úÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù.

ÇÁ·Î¸Þ°¡ ÄÚ¸®¾Æ À¯ÇÑȸ»ç´Â ½Å¾à°³¹ß, ºÐÀÚÁø´Ü, ÀÀ¿ë°úÇÐ ºÐ¾ß¿¡ »ç¿ëµÇ´Â ÇÙ»ê ¹× ´Ü¹éÁúÀ» ÃßÃâÇÒ ¼ö ÀÖ´Â ½Ã¾à ¹× ÀÚµ¿È­ Àåºñ¸¦ °³¹ß ¹× ÆÇ¸ÅÇÔÀ¸·Î½á »ý¸í°úÇÐ °ü·Ã ¿¬±¸°³¹ß¿¡ ±â¿©ÇÔÀ» ¸ñÀûÀ¸·Î ¼³¸³µÇ¾ú½À´Ï´Ù. ÇÁ·Î¸Þ°¡ ÄÚ¸®¾Æ¿¡¼­ °ø±ÞµÇ´Â ½Ã¾à ¹× ±â±â´Â ´ëÇבּ¸±â°ü, »ê¾÷ü R&D ¿¬±¸¼Ò, ±¹°¡ ¿¬±¸±â°ü, ´ëÇк´¿øÁø´Ü°Ë»çÀÇÇаú µî¿¡ °ø±ÞµÇ°í ÀÖ°í, ÇÁ·Î¸Þ°¡ ÄÚ¸®¾Æ´Â Çõ½ÅÀûÀÎ ±â¼ú·ÂÀ» °¡Áø Á¦Ç°ÀÇ °ø±Þ ¹× Á¦¹Ý ±â¼ú ¼­ºñ½º¸¦ Á¦°øÇÔÀ¸·Î½á ¼º°ú¸¦ âÃâÇϰíÀÚ ÇÕ´Ï´Ù.

¿¬Çõ


Founded: 1978
Founder: William A. Linton, Chairman and CEO
Ownership: Employees and investors; privately held
Number of Employees: 1,040
Number of Products: 2,000+
Patent Leadership: Promega holds nearly 900 patents and pending applications focused in the areas of:
  -Nucleic acid purification
  -Human identification
  -Bioluminescence
  -Coupled in vitro transcription and translation
  -Cell biology
Licensing: Promega offers licensing opportunities for a number of key technologies. Currently the following technologies are available for licensing:
  -Vector Label License - Green Fluorescent Protein
  -Vector Label License - Luciferase
  -Apoptosis Marker Antibodies
  -Short Tandem Repeats (STRs)
Annual Revenue: Over $250 million
Percent of Revenues Invested in R&D: 11%

º¹¸®ÈÄ»ý

  • ÈÞ¹«/±â³äÀÏÁÖ5Àϱٹ«,¿¬Â÷,¿ùÂ÷,°æÁ¶ÈÞ°¡
  • 4´ëº¸Çè±¹¹Î¿¬±Ý,ÀǷẸÇè,»êÀ纸Çè,°í¿ëº¸Çè
  • ±³À°/¿©°¡Áö¿øÀÚ±â°è¹ßÁö¿ø
  • º¸Àå/º¸»óÀμ¾Æ¼ºê,ÅðÁ÷±Ý
  • ±Ù¹«È¯°æ/ÆíÀǽĴë

±â¾÷À§Ä¡

  • ÁÖ¼Ò : ¼­¿ï °­¼­±¸ °¡¾çµ¿ 1498¹øÁö °­¼­ÇѰ­ÀÚÀÌŸ¿ö Aµ¿ 1013È£ Aµ¿ 1013È£ (°¡¾çµ¿,°­¼­ÇѰ­ÀÚÀÌŸ¿ö)
  • »ó¾Ïµ¿ DMC´ÜÁö³»

µ¿ÀÏ ±â¾÷ÀÌ¶óµµ Å¸Áö¿ª ä¿ëÀÇ °æ¿ì, ȸ»ç ÁÖ¼Ò¿Í Àα٠ÁöÇÏö Á¤º¸°¡ »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.